News
03-28-2010, 05:11 AM
Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women...
More... (http://mnt.to/f/3zxN)
More... (http://mnt.to/f/3zxN)